Neola Medical Valuation
| NEOLA Stock | 2.20 0.08 3.51% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Neola Medical AB secures a last-minute Real Value of USD1.96 per share. The latest price of the firm is USD2.2. Our model forecasts the value of Neola Medical AB from analyzing the firm fundamentals such as Profit Margin of (0.82) %, current valuation of 69.42 M, and Return On Equity of -0.23 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Neola Medical's price fluctuation is very risky at this time. Calculation of the real value of Neola Medical AB is based on 3 months time horizon. Increasing Neola Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Neola stock is determined by what a typical buyer is willing to pay for full or partial control of Neola Medical AB. Since Neola Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neola Stock. However, Neola Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.2 | Real 1.96 | Hype 2.2 | Naive 2.14 |
The intrinsic value of Neola Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Neola Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Neola Medical AB helps investors to forecast how Neola stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neola Medical more accurately as focusing exclusively on Neola Medical's fundamentals will not take into account other important factors: Neola Medical Total Value Analysis
Neola Medical AB is now projected to have takeover price of 69.42 M with market capitalization of 114.46 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Neola Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
69.42 M | 114.46 M |
Neola Medical Asset Utilization
One of the ways to look at asset utilization of Neola is to check how much profit was generated for every dollar of assets it reports. Neola Medical AB secures a negative usage of assets of -0.12 %, losing USD0.001247 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Neola Medical AB shows how discouraging it operates for each dollar spent on its assets.Neola Medical Ownership Allocation
Neola Medical AB maintains a total of 55.69 Million outstanding shares. Neola Medical AB secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.57 % of Neola Medical AB outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.About Neola Medical Valuation
The stock valuation mechanism determines Neola Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Neola Medical AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neola Medical. We calculate exposure to Neola Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neola Medical's related companies.8 Steps to conduct Neola Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Neola Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Neola Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Neola Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Neola Medical's revenue streams: Identify Neola Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Neola Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Neola Medical's growth potential: Evaluate Neola Medical's management, business model, and growth potential.
- Determine Neola Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Neola Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Neola Stock Analysis
When running Neola Medical's price analysis, check to measure Neola Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neola Medical is operating at the current time. Most of Neola Medical's value examination focuses on studying past and present price action to predict the probability of Neola Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neola Medical's price. Additionally, you may evaluate how the addition of Neola Medical to your portfolios can decrease your overall portfolio volatility.